Ellen Murray Howe
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Ellen Murray Howe
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Transportation Security Administration
2
| Government | General Government | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ellen Murray Howe
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Georgia Southern University | College/University | Undergraduate Degree | |
National Defense University | College/University | Graduate Degree | |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Investment Managers | Chief Executive Officer | |
ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Leucadia Therapeutics, Inc.
Leucadia Therapeutics, Inc. Medical SpecialtiesHealth Technology Leucadia Therapeutics, Inc. develops diagnostic algorithm for Alzheimer disease prevention and treatment. The firm?s therapeutic device is under pre-clinical testing to delay or prevent patients with mild cognitive impairment (MCI) from progressing to Alzheimer's disease. The company was founded by Doug Ethell and is headquartered in Delaware. | Medical Specialties | Director/Board Member | |
Methuselah Foundation | Chief Executive Officer | ||
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. BiotechnologyHealth Technology Turn Biotechnologies, Inc. engages in the development of solutions for reversing aging and age-related diseases. It focuses on achieving rejuvenation across cellular aging hallmarks in human fibroblasts and endothelial cells without the loss cellular identity. The company was founded by Jay Sarkar, Marco Quarta, and Vittorio Sebastiano and is headquartered in Mountain View, CA. | Biotechnology | Chairman | |
Volumetric Biotechnologies, Inc. | Director/Board Member |
Statistik
International
Vereinigte Staaten | 10 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David Gobel | 8 |
Stephen N. Wood | 3 |
- Börse
- Insiders
- Ellen Murray Howe
- Unternehmensverbindungen